Folliculitis-perifolliculitis related to erlotinib therapy spares previously irradiated skin - 08/08/11
Abstract |
Erlotinib, a specific epidermal growth factor receptor tyrosine kinase inhibitor, is used to treat various metastatic cancers. It is known to cause an acneiform rash. Herein, we report a case where the rash spared the previous radiotherapy field. A limitation of this study is that it is an anecdotal case report. Further research into the pathologic process of the rash is warranted to understand the reason for its absence in the irradiated skin.
Le texte complet de cet article est disponible en PDF.Plan
Funding sources: None. |
|
Conflicts of interest: None declared. |
|
Reprints not available from authors. |
Vol 60 - N° 1
P. 154-157 - janvier 2009 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?